Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.
about
Porous bead-based diagnostic platforms: bridging the gaps in healthcareApplication of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluidsCan Saliva Proteins Be Used to Predict the Onset of Acute Myocardial Infarction among High-Risk Patients?Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip.Programmable bio-nano-chip system: a flexible point-of-care platform for bioscience and clinical measurements.Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.A disposable bio-nano-chip using agarose beads for high performance immunoassays.Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid BiopsyInnovative Programmable Bio-Nano-Chip Digitizes Biology Using Sensors That Learn Bridging Biomarker Discovery and Clinical ImplementationMetabolic disease risk in children by salivary biomarker analysis.Saliva as a diagnostic fluid.Programmable nano-bio-chip sensors: analytical meets clinical.Current developments in salivary diagnostics.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Utility of salivary biomarkers for demonstrating acute myocardial infarction.Detection of homocysteine and C-reactive protein in the saliva of healthy adults: comparison with blood levelsEffects of the UK Biobank collection protocol on potential biomarkers in saliva.Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review.Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance.Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care.Salivary markers of inflammation in response to acute stress.Associations between the prenatal environment and cardiovascular risk factors in adolescent girls: Internalizing and externalizing behavior symptoms as mediators.HIV protease inhibitors alter innate immune response signaling to double-stranded RNA in oral epithelial cells: implications for immune reconstitution inflammatory syndrome?Whole-saliva proteolysis and its impact on salivary diagnostics.Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC).Assessing salivary C-reactive protein: longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violence.Location of biomarkers and reagents within agarose beads of a programmable bio-nano-chip.Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.Oral fluids that detect cardiovascular disease biomarkers.Application of nanomedicine in emergency medicine; Point-of-care testing and drug delivery in twenty - first centuryNext Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids.Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model.Perspective on diagnostics for global healthCurrent development of saliva/oral fluid-based diagnostics.Salivary diagnostics: a brief review.Salivary troponin I as an indicator of myocardial infarction.Saliva Liquid Biopsy for Point-of-Care Applications.Systematic antibody and antigen-based proteomic profiling with microarrays.Nanomedicine in cardiovascular therapy: recent advancements.
P2860
Q26829421-4DCB856A-BE02-4588-8E97-EC99DABE8D4FQ27312152-2F9819F3-371A-4300-8BF8-3D0ECCC60AB6Q28080787-D437382F-BDDB-44F1-B08B-B63FCA72A362Q30357486-C6D89AF5-FF30-46EA-A1B4-6196B6ADFC98Q30400807-CD4153CC-35E2-404D-A320-B890D3F8395EQ30475719-664E6C3A-EB50-432F-B80D-F7102A62FA35Q30503968-0D3B6A49-2A59-4942-9736-CE539C069D53Q33455416-1E128C02-9C01-413B-9E97-CD3B5DE7D297Q33717730-B721E8BC-1787-47AF-B388-0B50BA2EC732Q33733973-BA4587FA-EA88-4C66-BD49-9A27D6D96AF8Q33752749-7B3CD810-3D9C-4469-9571-57420B5ED766Q33785871-579F878A-BAFB-44B0-BAC9-AA88FA5C47BDQ33803001-4FEB3875-762E-44F3-B1D3-00CBC64098EEQ33839384-52A9C6E9-2F97-4D1A-9DD2-CB880786CE1FQ33936565-04D54607-16B7-4A47-A27C-57D04F6F4CB8Q34052672-23D0693E-0EF2-45F1-94F0-9D17FD4EF4E6Q34475428-4E7777B4-B0E1-4290-97F4-7DAE71D2295EQ34669387-F9E00E52-3EFB-4B9C-BB81-4881D63980F6Q34699161-CBD35F2D-78C6-464D-929F-0D2486B97C40Q34712257-CD63741D-03F7-4E82-84B5-2BAD12EF9FFCQ34764999-03F29E60-DF8E-40EA-BB45-7CB1A2D46B5DQ35149296-0707D369-63B8-4BD0-ADD5-3326E251EDFAQ35195370-377C7EAC-0A07-42C3-9079-22FE2D946025Q35282974-1CC99404-D6E3-44F5-8411-8E40587A1AACQ35672964-5B63A385-F9F6-4F86-8413-09AD0EE459F0Q35805764-6120FB5E-6140-4AC1-808F-8F85EFB735D6Q35906872-511C4654-21C2-4A10-AA40-956D92F91E06Q36096170-DDD87BD5-91FE-48F3-9502-9DAC9AD8967EQ36119303-A17D5C6E-662F-4C66-A618-D18C1FBBD95FQ36543444-704CA029-5F44-4C64-A658-DADB55091FC0Q36564556-8AD891C8-5874-4EE4-B035-A52EEFF93976Q36611756-153B7A9F-C79F-4BF4-875D-B393BB1D52CDQ37076854-46D1AE4E-A0EE-4A77-8D8E-B4C84D1E1730Q37092106-ED1A68AE-7FD0-4BAA-8681-5D1512706C98Q37092157-D6AA232D-AF9A-4754-95E9-38644A8C7FBBQ37588116-E9A8D328-8A0D-42A9-A932-6D6E8A7AC251Q37690823-D850307A-755E-4A2F-8490-064918CA7C9BQ37747010-3AB359B4-8E53-4A72-AD46-78D371349FE8Q37853185-4251D355-437B-4AE6-9ACF-6B52A4BF0DD9Q38034812-3E399A1C-ECDE-4ADF-829B-2C0BC249BE9B
P2860
Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@en
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@nl
type
label
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@en
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@nl
prefLabel
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@en
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@nl
P2093
P1433
P1476
Use of saliva-based nano-bioch ...... of care: a feasibility study.
@en
P2093
Beate G Rose
Chih-ko Yeh
Craig S Miller
Denis F Kinane
Jeffrey L Ebersole
John Spertus
M John Novak
Nicolaos Christodoulides
Pierre N Floriano
Priya Dharshan
P304
P356
10.1373/CLINCHEM.2008.117713
P407
P577
2009-06-25T00:00:00Z